MLPA-Based CNV Testing for BRCA1/BRCA2
HUSLAB Laboratory of Genetics at HUS (Helsinki University Hospital) Diagnostic Center is an SFS-EN ISO 15189:2022 accredited laboratory providing diagnostic and follow-up genetic testing services for patients within the Helsinki University Hospital area. The object of the procurement is an MLPA (Multiplex Ligation-dependent Probe Amplification) assay for the detection of copy number variations (CNVs) in BRCA1 and BRCA2 genes, including all reagents, controls, consumables, software, licences and other components req...
Buyer
HUS Group, the joint authority for Helsinki and Uusimaa
Value
Not provided
Published
8 Oct 2026
Closes
9 Nov 2026
Procurement details
Source
TED (EU)
Country
Finland (FI)
Procurement method
Open
Category
Goods
Contract starts
1 Feb 2027
Contract ends
Not provided
CPV classifications
33696500
Laboratory reagents
33000000
Medical equipments, pharmaceuticals and personal care products
Lots
Lot LOT-0000 MLPA-Based CNV Testing for BRCA1/BRCA2
Value not provided
HUSLAB Laboratory of Genetics at HUS (Helsinki University Hospital) Diagnostic Center is an SFS-EN ISO 15189:2022 accredited laboratory providing diagnostic and follow-up genetic testing services for patients within the Helsinki University Hospital area. The object of the procurement is an MLPA (Multiplex Ligation-dependent Probe Amplification) assay for the...
Delivery: FI1B1 · Finland
Documents
Unlock document linkTED notice 694407-2026
8 Oct 2026
Tender notice · Web page
Procurement documents
Not provided
Bidding documents
Contains information from TED (Tenders Electronic Daily), © European Union, reused under CC BY 4.0.